QLC5513
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for QLC5513, covering 2025-12-09 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC. [Phase 2]